ArticleFrontiers in oncology2026
Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
Abstract
Objective: To analyze the surgical treatment and prognosis of patients with advanced epithelial ovarian cancer with intestinal metastases. Methods: A retrospective study was conducted on 255 patients diagnosed with epithelial ovarian cancer stage III or IV with bowel metastases between January 1st, 2015 and December 31st, 2020, divided into two groups, the study group was the bowel resection group (101 cases), and the control group was the bowel tumor stripping group (154 cases). Results: R0 rate reached 75.4% in this cohort study. Patients in the bowel resection group were more likely to be in stage IV and had higher surgical complexity scores ( Conclusion: Bowel tumor stripping does not negatively affect the prognosis of advanced ovarian cancer if R0 cytoreductive surgery is achieved. Excessive bowel resection does not improve overall survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.